System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe.
about
An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia managementMagnesium sulphate versus phenytoin for eclampsiaMagnesium sulphate versus diazepam for eclampsiaWhy are women dying when they reach hospital on time? A systematic review of the 'third delay'Global Forum 2015 dialogue on "From evidence to policy - thinking outside the box": perspectives to improve evidence uptake and good practices in the African Region.Feasibility of community level interventions for pre-eclampsia: perspectives, knowledge and task-sharing from Nigeria, Mozambique, Pakistan and India.Evidence-informed health policy 4 - case descriptions of organizations that support the use of research evidence.Community health worker knowledge and management of pre-eclampsia in southern MozambiqueMarket failure and the poverty of new drugs in maternal healthMagnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen.Translating research into policy: lessons learned from eclampsia treatment and malaria control in three southern African countries.Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy.Research, evidence and policymaking: the perspectives of policy actors on improving uptake of evidence in health policy development and implementation in UgandaBenefits of using magnesium sulphate (MgSO₄) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria.Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practiceFactors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking?SUPPORT Tools for evidence-informed health Policymaking (STP) 2: Improving how your organisation supports the use of research evidence to inform policymakingMagnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be.Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort studyImproving emergency obstetric care in Mozambique: the story of Sofala.Addressing inequalities in research capacity in Africa.A review of the process of knowledge transfer and use of evidence in reproductive and child health in GhanaScreening and management of pre-eclampsia and eclampsia in antenatal and labor and delivery services: findings from cross-sectional observation studies in six sub-Saharan African countries
P2860
Q21261344-C6A2C2A0-8448-49BC-9BCE-F319903271AEQ24234534-342BDE4C-93F3-4684-A1AB-621F9C332F80Q24235678-59E41F58-216C-415C-9610-7AA4821EBFAFQ28533159-E207EED5-260D-45CB-8109-6BC361F8510EQ30061989-D83C9EC5-E190-485A-8C13-FE924ADDAB33Q30381329-2410DEA5-507B-46BC-B22F-B1732B7241E1Q30485953-6E20541E-B2A8-4E6C-BC53-7495F670B665Q30820061-ABBCA4AF-A634-44EA-8A29-F1A28CA5E54AQ33316160-D48AC570-3FF6-4A35-ACFB-F65458BCB0D7Q33494967-FFCC8B31-6F89-47D1-B1C7-85F7783D256DQ33601366-0B4ABEA1-6316-4582-8800-EACC56F5F36DQ33772816-D4474E65-7613-41F9-975A-80C768DEDF58Q33875780-FEAAB6E0-C4AA-4477-ADF6-444055455B73Q34153506-BF295F24-318C-4AC5-B5AA-47F2D72DE08DQ34371081-80CB240E-EEDF-4DC2-8B5F-6EAC33E4917CQ34650803-42824BCB-29FE-41C9-BF0F-94E924914D28Q35650537-3F86F075-039C-4539-B24C-9721EF6CDDB7Q35734405-8908CE6E-6986-4EFC-96C2-6CA929A0719CQ35734497-35EBD94E-A9C3-4468-97AC-B901BB126506Q37085163-D3491FF2-CF59-4B74-9F4E-943E0450D2E8Q37612215-D5620F8B-D45F-4495-A43E-31C53337BC61Q38452197-94963B82-611B-4030-A0CD-5281EB9C8278Q42548300-723638BD-5691-4A35-B7B2-AFC556BE626DQ56334950-E8745369-BE93-400B-B21B-A7DE3E43989FQ58713591-9F039429-87EA-4060-8173-1395A7246742
P2860
System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
System and market failures: th ...... ia in Mozambique and Zimbabwe.
@ast
System and market failures: th ...... ia in Mozambique and Zimbabwe.
@en
type
label
System and market failures: th ...... ia in Mozambique and Zimbabwe.
@ast
System and market failures: th ...... ia in Mozambique and Zimbabwe.
@en
prefLabel
System and market failures: th ...... ia in Mozambique and Zimbabwe.
@ast
System and market failures: th ...... ia in Mozambique and Zimbabwe.
@en
P2093
P2860
P921
P356
P1433
P1476
System and market failures: th ...... ia in Mozambique and Zimbabwe.
@en
P2093
B Fernandes
S Matinhure
P2860
P304
P356
10.1136/BMJ.331.7519.765
P407
P577
2005-10-01T00:00:00Z